The Israeli Institute for biological studies has completed the development phase of the antibody from COVID-19 or passive vaccine. This is now written edition of The Jerusalem Post , citing a statement from the Ministry of defense of Israel.
The defense Minister Naftali Bennett visited the Institute for biological research in ness Ziona, where he got acquainted with the work of scientists engaged in developing tools from the coronavirus, the newspaper writes. We are talking about the antibody that attacks the virus and neutralizes it in the body.
Now the Institute works on patent, after which scientists will be able to turn to international companies for the production of drugs for the treatment of patients.
An outbreak of coronavirus SARS-CoV-2 began in December of 2019 in China. March 11, 2020, the world health organization declared the spread of the coronavirus pandemic.
According to data from the American Johns Hopkins University, coronavirus in the world were infected more than 3.58 million people, more than 251,5 thousand of them died, and 1.16 million recovered.
Special medications from coronavirus infection COVID-19 does not exist now in this disease is only symptomatic treatment. The world health organization notedthat a number of medicines can contribute to improved well-being and relief of symptoms COVID-19, but there is no evidence that any drug to prevent or treat the disease.
Who believe that the coronavirus would pose a serious threat, until they invent a vaccine. Now, according to the organization, in the world is developed not less than 70 vaccines against coronavirus.